Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

aap Implantate (AAQ1) Stock Price & Analysis

2 Followers

AAQ1 Stock Chart & Stats

€1.38-€0.03(-2.13%)
At close: 5:30 PM GMT+1
€1.4€1.5€1.6€1.7Aug 17Aug 31Sep 14Sep 28Oct 12Oct 26Nov 9
Day’s Range
EUR 1.35 - EUR 1.41
52-Week Range
EUR 1.26 - EUR 2.34
Previous Close
EUR 1.41
Volume
N/A
Average Volume (3M)
1,412
Market Cap
EUR 22.36M
Enterprise Value
EUR 28.81M
Total Cash (Recent Filing)
EUR 286.00K
Total Debt (Recent Filing)
EUR 3.97M
Price to Earnings (P/E)
―
Beta
-0.14
Next Earnings
Aug 18, 2027 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Strong Gross Margin

An approximately 82% gross margin indicates strong product-level economics in the company’s orthopedic implant activities. This provides a substantial base to absorb operating costs, support product development, and potentially improve profitability if revenue scale and cost discipline strengthen over the next several quarters.

Manageable Leverage

Low leverage and a meaningful equity cushion reduce the immediate burden of debt service and preserve financial flexibility. Compared with a heavily debt-funded structure, this leaves the company better positioned to manage operating volatility and direct available resources toward sustaining its orthopedic business.

Specialized Orthopedic Focus

A focused portfolio in trauma and orthopedic applications gives the company a clearly defined healthcare niche and links its products to surgical procedures. This specialization can support durable commercial relevance with hospitals and surgeons, provided the company converts its product expertise into sustainable sales.

Bears Say

Persistent Unprofitability

Continued net losses show that strong gross profitability is not currently sufficient to cover the company’s operating cost base. Persistently negative returns on equity also indicate that capital is not yet compounding through earnings, limiting internal funding capacity and weakening long-term financial resilience.

Ongoing Cash Burn

Negative operating and free cash flow indicate that the core business is consuming cash rather than funding itself. Continued cash burn can create recurring funding needs, restrict investment in commercial development, and leave less flexibility to absorb weaker trading or pursue growth without additional resources.

Recent Revenue Decline

The approximately 10% TTM revenue decline signals weakening commercial momentum after a period of relatively stable revenue. If the contraction persists, lower sales volume could reduce operating leverage and make it harder for the company to spread costs sufficiently to reach sustained profitability.

AAQ1 FAQ

What was aap Implantate’s price range in the past 12 months?
aap Implantate lowest stock price was €1.26 and its highest was €2.34 in the past 12 months.
What is aap Implantate’s market cap?
aap Implantate’s market cap is €22.36M.
When is aap Implantate’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were aap Implantate’s earnings last quarter?
aap Implantate released its earnings results on Aug 17, 2026. The company reported -€0.08 earnings per share for the quarter.
Is aap Implantate overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does aap Implantate pay dividends?
aap Implantate does not currently pay dividends.
What is aap Implantate’s EPS estimate?
aap Implantate’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does aap Implantate have?
aap Implantate has 16,203,537 shares outstanding.
What happened to aap Implantate’s price movement after its last earnings report?
aap Implantate reported an EPS of -€0.08 in its last earnings report. Following the earnings report the stock price went up 5.333%.
Which hedge fund is a major shareholder of aap Implantate?
Currently, no hedge funds are holding shares in DE:AAQ1
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology